Acquiring Company
Esteve
Acquired Company
TerSera
Description
ESTEVE has closed the acquisition of the Infusion Business Unit of TerSera, enhancing its specialty pharma portfolio. This acquisition adds two highly specialized pharma drugs and integrates eight new products over the last 18 months. Additionally, ESTEVE has acquired Regis Technologies to boost its CDMO capabilities in the U.S. market. These strategic moves support ESTEVE's dual focus on pharmaceuticals and CDMO growth.
Who to call at Esteve, and when
When Esteve changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Esteve raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Esteve, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Esteve. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Esteve makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired TerSera?
TerSera was acquired by Esteve, based in Barcelona. The deal was reported on May 4, 2026. Esteve is a global pharmaceutical company headquartered in Barcelona, focused on providing solutions for unmet medical needs. Esteve is privately held and operates in Manufacturing.
When did Esteve acquire TerSera?
Esteve's acquisition of TerSera was reported on May 4, 2026. ESTEVE has closed the acquisition of the Infusion Business Unit of TerSera, enhancing its specialty pharma portfolio. This acquisition adds two highly specialized pharma drugs and integrates eight new products over the last 18 months. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does TerSera do?
TerSera is a pharmaceutical company based in the United States. It specializes in developing and providing access to specialty pharmaceutical products. The company has a focus on oncology and endocrinology. It is privately held, operating in Manufacturing, and is based in Illinois.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.